This study is looking at new ways to help people in rural areas manage their Type 2 Diabetes. It tests an approach called Acceptance and Commitment Therapy (ACT), which helps you accept difficult feelings and focus on actions that align with your values. This therapy is combined with the Abbott FreeStyle® Libre® 3, a device that continuously monitors your blood sugar, and general education about lifestyle choices for diabetes. The main goal is to see if this combination can lower your Hemoglobin A1C (a measure of average blood sugar over 2-3 months) after one year. You might be able to join if you are 18 or older, have Type 2 Diabetes with an A1C of 6.0 or higher, speak English, have a smartphone, and live in a rural area.

Study design

This is an interventional study planning to enroll 60 participants. It is designed as a randomized controlled trial, comparing different combinations of interventions.

What's involved

You would receive approximately 3 hours of Acceptance and Commitment Therapy, use the Abbott FreeStyle® Libre® 3 for 12 weeks, and receive general education on diabetes management.

Compensation

Not stated in the trial record.

Follow-up

Your Hemoglobin A1C will be measured at 1-year after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.